Beyond Methotrexate and Biologics in RA – Efficacy of JAK Inhibitors and their Place in the Current Treatment Armamentarium

Beyond Methotrexate and Biologics in RA – Efficacy of JAK Inhibitors and their Place in the Current Treatment Armamentarium

Bibliographic Details
Main Author:	Katerina Chatzidionysiou
Format:	Article
Language:	English
Published:	PCO Convin S.A. 2020-01-01
Series:	Mediterranean Journal of Rheumatology
Subjects:	jak inhibitors methotrexate biologics treatment rheumatoid arthritis
Online Access:	http://mjrheum.org/assets/files/792/file226_1140.pdf

Similar Items

JAK ACADEMY in Rheumatoid Arthritis (RA)
by: Roberto Caporali, et al.
Published: (2018-09-01)

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes
by: Mark Genovese, et al.
Published: (2018-03-01)

JAK inhibitors for the treatment of rheumatoid arthritis
by: Akio Morinobu
Published: (2020-10-01)

JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
by: Rita A. Moura, et al.
Published: (2021-02-01)

Relationship between methotrexate dose and clinical efficacy for treatment of rheumatoid arthritis
by: HE Longquan, et al.
Published: (2020-09-01)

Methotrexate in Treatment of Rheumatoid Arthritis
by: Wiewiόrowski Maciej, et al.
Published: (1999-08-01)

Basic Mechanisms of JAK Inhibition
by: Chung MA Lin, et al.
Published: (2020-01-01)

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494)
by: Julie M. Parmentier, et al.
Published: (2018-08-01)

New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors
by: Masaru Kato
Published: (2020-04-01)

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
by: Borja Hernández-Breijo, et al.
Published: (2021-06-01)

Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors
by: Blaž Burja, et al.
Published: (2020-05-01)

Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)
by: E. L. Nasonov, et al.
Published: (2020-02-01)

The marked and rapid therapeutic effect of tofacitinib in combination with subcutaneous methotrexate in a rheumatoid arthritis patient with poor prognostic factors who is resistant to standard disease-modifying antirheumatic drugs and biologicals: A clinical case
by: N. V. Demidova, et al.
Published: (2016-03-01)

JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data
by: Harrington R, et al.
Published: (2020-09-01)

Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
by: Almalag H, et al.
Published: (2020-09-01)

Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis
by: Zhang N, et al.
Published: (2021-05-01)

Methotrexate in the treatment of rheumatic disease
by: Marina Zinovyevna Kanevskaya, et al.
Published: (2013-12-01)

Pain in Rheumatoid Arthritis: Could JAK Inhibition be the Answer?
by: Puja Mehta, et al.
Published: (2020-01-01)

High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
by: Jéssica Martins Amaral, et al.
Published: (2020-08-01)

A new player in psoriatic arthritis: a JAK inhibitor
by: Lazaros I. Sakkas
Published: (2017-01-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-10-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2016-12-01)

Pancytopenia and stomatitis induced by low-dose methotrexate use
by: Hüseyin Yildiz, et al.
Published: (2017-01-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-09-01)

The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
by: G. I. Gridneva, et al.
Published: (2019-05-01)

NEW RECOMMENDATIONS FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE ROLE OF METHOTREXATE
by: Evgeniy L Nasonov, et al.
Published: (2014-03-01)

USE OF SUBCUTANEOUS METHOTREXATE FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: D. E. Karateev, et al.
Published: (2016-07-01)

Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy
by: Tsutomu Takeuchi, et al.
Published: (2021-08-01)

Treatment of Rheumatoid Arthritis with Methotrexate Alone or A Combination of Methotrexate and Hydroxychloroquine
by: Natharubini Nadarajah, et al.
Published: (2016-09-01)

The progress of rheumatology in the 21st century potential uses of upadacitinib in rheumatoid arthritis and other inflammatory rheumatic diseases
by: E. L. Nasonov, et al.
Published: (2020-11-01)

NEW APPROACHES TO PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: TOFACITINIB
by: E. L. Nasonov
Published: (2014-06-01)

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
by: Przemysław J. Kotyla, et al.
Published: (2020-10-01)

Reactivation of latent tuberculosis associated with methotrexate therapy
by: Pirasath Selladurai, et al.
Published: (2019-05-01)

Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis
by: Kylie Greenwald, et al.
Published: (2020-07-01)

Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis
by: Alejandro Escudero-Contreras, et al.
Published: (2021-09-01)

Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review
by: Tornero Molina J, et al.
Published: (2021-03-01)

Ferulaldehyde Improves the Effect of Methotrexate in Experimental Arthritis
by: Lukáš Slovák, et al.
Published: (2017-11-01)

The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study
by: M. Manara, et al.
Published: (2016-12-01)

Methotrexate-induced Hypersensitivity Pneumonitis appearing after 30 years of use: a case report
by: Mashal Salehi, et al.
Published: (2017-06-01)

METHOTREXATE — «GOLD STANDARD» OF JUVENILE RHEUMATOID ARTHRITIS TREATMENT
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)